| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.34B | 38.35B | 34.18B | 34.07B | 30.09B | 28.44B |
| Gross Profit | 10.03B | 9.75B | 8.30B | 7.71B | 6.89B | 6.23B |
| EBITDA | 5.72B | 6.82B | 4.58B | 3.91B | 2.97B | 2.77B |
| Net Income | 3.90B | 3.78B | 2.42B | 2.04B | 2.06B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 80.60B | 82.70B | 82.02B | 70.98B | 67.30B | 65.20B |
| Cash, Cash Equivalents and Short-Term Investments | 9.19B | 12.91B | 13.84B | 14.87B | 17.34B | 15.12B |
| Total Debt | 5.00B | 5.00B | 5.00B | 21.00M | 34.00M | 9.00M |
| Total Liabilities | 21.15B | 22.68B | 21.72B | 14.68B | 12.93B | 11.87B |
| Stockholders Equity | 59.09B | 59.65B | 59.98B | 56.16B | 54.24B | 53.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -771.00M | -6.13B | -3.49B | 1.35B | 2.58B |
| Operating Cash Flow | 0.00 | 4.72B | -461.00M | 1.49B | 3.15B | 3.93B |
| Investing Cash Flow | 0.00 | -3.30B | -3.82B | -2.81B | -159.00M | -563.00M |
| Financing Cash Flow | 0.00 | -2.40B | 3.83B | -1.00B | -863.00M | -803.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥32.34B | 13.03 | ― | 4.00% | 4.62% | 39.04% | |
76 Outperform | ¥56.32B | 12.94 | ― | 2.84% | 2.55% | 1.34% | |
72 Outperform | ¥43.00B | 22.03 | ― | 1.94% | 14.09% | -18.06% | |
72 Outperform | ¥38.13B | 9.82 | ― | 3.65% | 20.08% | 67.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥43.99B | 25.15 | ― | 1.96% | 6.56% | 24.04% | |
59 Neutral | ¥32.36B | 59.02 | ― | 2.19% | 1.69% | -67.19% |